Skip to content

Investigating the effect of psychological behavior modification by performing blood glucose self-care using Flash glucose monitoring at diabetes treatment commencement

Investigating the effect of psychological behavior modification by performing blood glucose self-care using Flash glucose monitoring at diabetes treatment commencement - Investigating the effect of psychological behavior modification by performing blood glucose self-care using Flash glucose monitoring at diabetes treatment commencement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036694
Enrollment
36
Registered
2019-12-31
Start date
2019-01-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 diabetes mellitus

Interventions

15 patients who voluntarily requested to wear FGM [Libre] for 2 to 4 weeks at the beginning of treatment. 15 patients who voluntarily requested to wear non FGM [Libre] at the beginning of treatment.

Sponsors

Futata Tetsuhiro Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who had type2 diabetes mellitus pointed out for the first time over 20 year old (untreated at registration).

Exclusion criteria

Exclusion criteria: Insulin-dependent patients. The patients who have had diabetes pointed out in the past.

Design outcomes

Primary

MeasureTime frame
4 questionnaire surveys were conducted during the treatment monitoring period at 1 month, at 3 months, at 6 month and at 12 months. Feelings regarding diabetes treatment were evaluated and categorized based on 10 different levels, Lifestyle changes were evaluated and categorized based on 5 different levels, Diabetes Treatment Satisfaction Questionnaire was evaluated and categorized based on 7 different levels, and Problem Areas In Diabetes were evaluated and categorized based on 5 different levels.

Secondary

MeasureTime frame
We follow up continuously during a 12 months treatment period. Comparisons were carried out based on BMI, blood pressure, HbA1c, PG, LDLC, HDLC, TG, AST, ALT, GGTP, eGFR.

Countries

Japan

Contacts

Public ContactShuichi Sato

Futata Tetsuhiro Clinic Department of Internal Medicine, Endocrinology, Metabolism and Diabetes

s.sato@futata-cl.jp092-738-1230

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026